| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/BOR.0B013E3283562C3E |
| P698 | PubMed publication ID | 22832823 |
| P2093 | author name string | Keith B Elkon | |
| Alice Wiedeman | |||
| P433 | issue | 5 | |
| P304 | page(s) | 499-505 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Current Opinion in Rheumatology | Q15750473 |
| P1476 | title | Type I IFN system in the development and manifestations of SLE. | |
| P478 | volume | 24 |
| Q57018017 | "Toll-free" pathways for production of type I interferons |
| Q36557899 | 12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis |
| Q57297471 | ARID3a gene profiles are strongly associated with human interferon alpha production |
| Q37224632 | Alterations in nuclear structure promote lupus autoimmunity in a mouse model. |
| Q35483850 | Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms |
| Q60913120 | Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus |
| Q56806670 | Autoantibodies in SLE: Specificities, Isotypes and Receptors |
| Q33403747 | Autoimmunity: homeostasis of innate immunity gone awry |
| Q38690844 | Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art. |
| Q37058781 | Biomarkers in systemic lupus erythematosus: challenges and prospects for the future |
| Q36983038 | C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes |
| Q27016554 | Cardiovascular disease in lupus: insights and updates |
| Q35722457 | Chemical biology of protein arginine modifications in epigenetic regulation |
| Q46001595 | Complement deficiencies and susceptibility to systemic lupus erythematosus revisited. |
| Q92766138 | Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells |
| Q45020306 | Cutting Edge: Plasmacytoid Dendritic Cells in Late-Stage Lupus Mice Defective in Producing IFN-α. |
| Q35589645 | Cutting edge: Antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction |
| Q26749296 | Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools |
| Q36515404 | Detection and identification of protein citrullination in complex biological systems |
| Q35051889 | Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates |
| Q38070990 | Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases |
| Q26771128 | Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? |
| Q34004649 | Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus |
| Q38192683 | Emerging biological therapies for systemic lupus erythematosus |
| Q38161582 | Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity |
| Q37099708 | Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors |
| Q51317974 | Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus. |
| Q89060748 | Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation |
| Q92967092 | Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus |
| Q51062941 | Gender bias in lupus: does immune response initiated in the gut mucosa have a role? |
| Q34230520 | Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus |
| Q37497741 | Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population |
| Q89531004 | Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice |
| Q40226730 | Haploinsufficiency of NADPH Oxidase Subunit Neutrophil Cytosolic Factor 2 Is Sufficient to Accelerate Full-Blown Lupus in NZM 2328 Mice |
| Q42252634 | High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus |
| Q37210594 | IFNα Inducible Models of Murine SLE. |
| Q41688983 | Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus. |
| Q26824391 | Idiosyncratic adverse drug reactions: current concepts |
| Q30410652 | Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure |
| Q28602250 | Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases |
| Q92952961 | Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy |
| Q34535634 | Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis |
| Q98196886 | Mapping systemic lupus erythematosus heterogeneity at the single-cell level |
| Q37612885 | Metabolic Factors that Contribute to Lupus Pathogenesis |
| Q36437284 | Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases |
| Q34729999 | Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding. |
| Q90999423 | Nucleosomal dsDNA Stimulates APOL1 Expression in Human Cultured Podocytes by Activating the cGAS/IFI16-STING Signaling Pathway |
| Q35060808 | Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice |
| Q34290113 | Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis |
| Q38178160 | Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. |
| Q28603356 | Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies |
| Q58556211 | Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease |
| Q38193734 | Possible novel biomarkers of organ involvement in systemic lupus erythematosus |
| Q40596271 | Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity |
| Q64939151 | REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A). |
| Q55122208 | Regulation of the Interferon Response by lncRNAs in HCV Infection. |
| Q47912211 | Self-dsDNA in the pathogenesis of systemic lupus erythematosus. |
| Q38650724 | T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis |
| Q35202579 | TLR7 influences germinal center selection in murine SLE. |
| Q27023982 | TLRs and interferons: a central paradigm in autoimmunity |
| Q39328254 | TRIM dsDNA sensor to restrict innate immune response |
| Q38662898 | Therapeutic potential of regulatory cytokines that target B cells |
| Q51075145 | Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism. |
| Q38840206 | Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus |
| Q35451036 | Type I interferon controls propagation of long interspersed element-1. |
| Q50272850 | Ultraviolet B Irradiation Causes Stimulator of Interferon Genes-Dependent Production of Protective Type I Interferon in Mouse Skin by Recruited Inflammatory Monocytes |
| Q38920435 | Why targeted therapies are necessary for systemic lupus erythematosus |
| Q38274918 | lncRNA-mediated regulation of the interferon response |
Search more.